Pharmaceuticals

Europe Fidaxomicin Market Report 2016

  • QYR905910
  • 95 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In the last several years, Europe market of Fidaxomicin developed rapidly, with CAGR of 34%. In 2015, Europe Market Size of Fidaxomicin is nearly 16 M USD; the actual production is about 280 K Tablets.

This report studies sales (consumption) of Fidaxomicin in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these regions, covering

Astellas

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Fidaxomicin in these regions, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Benelux

Spain

Split by applications, this report focuses on sales, market share and growth rate of Fidaxomicin in each application, can be divided into

Hospital

Retail Pharmacies

Table of Contents

1 Fidaxomicin Overview 1

1.1 Product Overview and Scope of Fidaxomicin 1

1.2 Specifications of Fidaxomicin 2

1.3 Applications of Fidaxomicin 3

1.4 Fidaxomicin Market by Countries 5

1.4.1 Germany Status and Prospect (2011-2021) 5

1.4.2 France Status and Prospect (2011-2021) 6

1.4.3 UK Status and Prospect (2011-2021) 7

1.4.4 Russia Status and Prospect (2011-2021) 7

1.4.5 Italy Status and Prospect (2011-2021) 8

1.4.6 Benelux Status and Prospect (2011-2021) 9

1.4.7 Spain Status and Prospect (2011-2021) 9

1.5 Europe Market Size (Value and Volume) of Fidaxomicin (2011-2021) 10

1.5.1 Europe Fidaxomicin Sales and Growth Rate (2011-2021) 10

1.5.2 Europe Fidaxomicin Revenue and Growth Rate (2011-2021) 11

2 Europe Fidaxomicin by Manufacturers, Type and Application 12

2.1 Europe Fidaxomicin Market Competition by Manufacturers 12

2.1.1 Europe Fidaxomicin Sales and Market Share of Key Manufacturers (2015 and 2016) 12

2.1.2 Europe Fidaxomicin Revenue and Share by Manufacturers (2015 and 2016) 13

2.2 Europe Fidaxomicin (Volume and Value) by Countries 14

2.2.1 Europe Fidaxomicin Sales and Market Share by Countries (2012-2016) 14

2.2.2 Europe Fidaxomicin Revenue and Market Share by Countries (2012-2016) 16

2.3 Europe Fidaxomicin (Volume) by Application 17

3 Germany Fidaxomicin (Volume, Value and Sales Price) 20

3.1 Germany Fidaxomicin Sales and Value (2012-2016) 20

3.1.1 Germany Fidaxomicin Sales and Growth Rate (2012-2016) 20

3.1.2 Germany Fidaxomicin Revenue and Growth Rate (2012-2016) 21

3.1.3 Germany Fidaxomicin Sales Price Trend (2012-2016) 21

3.2 Germany Fidaxomicin Sales and Market Share by Manufacturers 22

3.3 Germany Fidaxomicin Sales and Market Share by Applications 22

4 UK Fidaxomicin (Volume, Value and Sales Price) 24

4.1 UK Fidaxomicin Sales and Value (2012-2016) 24

4.1.1 UK Fidaxomicin Sales and Growth Rate (2012-2016) 24

4.1.2 UK Fidaxomicin Revenue and Growth Rate (2012-2016) 25

4.1.3 UK Fidaxomicin Sales Price Trend (2012-2016) 26

4.2 UK Fidaxomicin Sales and Market Share by Manufacturers 26

4.3 UK Fidaxomicin Sales and Market Share by Applications 27

5 France Fidaxomicin (Volume, Value and Sales Price) 28

5.1 France Fidaxomicin Sales and Value (2012-2016) 28

5.1.1 France Fidaxomicin Sales and Growth Rate (2012-2016) 28

5.1.2 France Fidaxomicin Revenue and Growth Rate (2012-2016) 29

5.1.3 France Fidaxomicin Sales Price Trend (2012-2016) 29

5.2 France Fidaxomicin Sales and Market Share by Manufacturers 30

5.3 France Fidaxomicin Sales and Market Share by Applications 30

6 Russia Fidaxomicin (Volume, Value and Sales Price) 32

6.1 Russia Fidaxomicin Sales and Value (2012-2016) 32

6.1.1 Russia Fidaxomicin Sales and Growth Rate (2012-2016) 32

6.1.2 Russia Fidaxomicin Revenue and Growth Rate (2012-2016) 33

6.1.3 Russia Fidaxomicin Sales Price Trend (2012-2016) 33

6.2 Russia Fidaxomicin Sales and Market Share by Manufacturers 34

6.3 Russia Fidaxomicin Sales and Market Share by Applications 34

7 Benelux Fidaxomicin (Volume, Value and Sales Price) 36

7.1 Benelux Fidaxomicin Sales and Value (2012-2016) 36

7.1.1 Benelux Fidaxomicin Sales and Growth Rate (2012-2016) 36

7.1.2 Benelux Fidaxomicin Revenue and Growth Rate (2012-2016) 37

7.1.3 Benelux Fidaxomicin Sales Price Trend (2012-2016) 37

7.2 Benelux Fidaxomicin Sales and Market Share by Manufacturers 38

7.3 Benelux Fidaxomicin Sales and Market Share by Applications 38

8 Italy Fidaxomicin (Volume, Value and Sales Price) 40

8.1 Italy Fidaxomicin Sales and Value (2012-2016) 40

8.1.1 Italy Fidaxomicin Sales and Growth Rate (2012-2016) 40

8.1.2 Italy Fidaxomicin Revenue and Growth Rate (2012-2016) 41

8.1.3 Italy Fidaxomicin Sales Price Trend (2012-2016) 41

8.2 Italy Fidaxomicin Sales and Market Share by Manufacturers 42

8.3 Italy Fidaxomicin Sales and Market Share by Applications 42

9 Spain Fidaxomicin (Volume, Value and Sales Price) 44

9.1 Spain Fidaxomicin Sales and Value (2012-2016) 44

9.1.1 Spain Fidaxomicin Sales and Growth Rate (2012-2016) 44

9.1.2 Spain Fidaxomicin Revenue and Growth Rate (2012-2016) 45

9.1.3 Spain Fidaxomicin Sales Price Trend (2012-2016) 45

9.2 Spain Fidaxomicin Sales and Market Share by Manufacturers 46

9.3 Spain Fidaxomicin Sales and Market Share by Applications 46

10 Europe Fidaxomicin Suppliers Analysis 48

10. 1 Company Basic Information 48

10.2 Product Information 49

10.3 Astellas Fidaxomicin Sales, Revenue, Price and Gross Margin 2015-2016 50

11 Fidaxomicin Manufacturing Cost Analysis 51

11.1 Fidaxomicin Key Raw Materials Analysis 51

11.1.1 Key Raw Materials 51

11.1.2 Key Suppliers of Raw Materials 52

11.1.3 Market Concentration Rate of Raw Materials 53

11.2 Proportion of Manufacturing Cost Structure 54

11.2.1 Raw Materials 54

11.2.2 Labor Cost 55

11.2.3 Manufacturing Expenses 55

11.3 Manufacturing Process Analysis of Fidaxomicin 55

12 Industrial Chain, Sourcing Strategy and Downstream Buyers 57

12.1 Fidaxomicin Industrial Chain Analysis 57

12.2 Upstream Raw Materials Sourcing 57

12.3 Downstream Buyers 58

13 Marketing Strategy Analysis, Distributors/Traders 59

13.1 Marketing Channel 59

10.1.1 Direct Marketing 60

10.1.2 Indirect Marketing 60

10.1.3 Marketing Channel Development Trend 60

13.2 Market Positioning 61

13.2.1 Pricing Strategy 61

13.2.2 Brand Strategy 62

13.2.2.1 Introducing pharmaceutical branding strategies 62

13.2.2.2 Building pharmaceutical brands 63

13.2.2.3 Communicating pharmaceutical brands 64

13.2.2.4 Alternative brand models 65

13.2.2.5 The future of pharmaceutical branding 66

13.3 Distributors/Traders List 67

14 Europe Fidaxomicin Market Forecast (2016-2021) 69

14.1 Germany Fidaxomicin Sales Forecast (2016-2021) 69

14.2 UK Fidaxomicin Sales Forecast (2016-2021) 70

14.3 France Fidaxomicin Sales Forecast (2016-2021) 71

14.4 Russia Fidaxomicin Sales Forecast (2016-2021) 73

14.5 Benelux Fidaxomicin Sales Forecast (2016-2021) 74

14.6 Italy Fidaxomicin Sales Forecast (2016-2021) 75

14.7 Spain Fidaxomicin Sales Forecast (2016-2021) 76

14.8 Europe Fidaxomicin Sales Forecast by Application (2016-2021) 77

15 Research Findings and Conclusion 78

16 Appendix 79

Author List 79

Disclosure Section 79

Research Methodology 80

Data Source 82

Disclaimer 82

List of Tables and Figures

Figure Picture of Fidaxomicin 1

Table Specifications of Fidaxomicin 2

Table Applications of Fidaxomicin 3

Figure Europe Sales Market Share of Fidaxomicin by Applications in 2015 5

Figure Germany Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 5

Figure France Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 6

Figure UK Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 7

Figure Russia Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 7

Figure Italy Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 8

Figure Benelux Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 9

Figure Spain Fidaxomicin Revenue and Growth Rate (2011-2021) 9

Figure Europe Fidaxomicin Sales (K Tablets) and Growth Rate (2011-2021) 10

Figure Europe Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 11

Table Europe Fidaxomicin Sales (K Tablets) of Key Manufacturers (2015 and 2016) 12

Table Europe Fidaxomicin Sales Share by Manufacturers (2015 and 2016) 12

Figure 2015 Fidaxomicin Sales Share by Manufacturers 13

Table Europe Fidaxomicin Revenue (M USD) by Manufacturers (2015 and 2016) 13

Table Europe Fidaxomicin Revenue Share by Manufacturers (2015 and 2016) 13

Table 2015 Europe Fidaxomicin Revenue Share by Manufacturers 14

Table Europe Fidaxomicin Sales (K Tablets) and Market Share by Countries (2012-2016) 14

Table Europe Fidaxomicin Sales Share by Countries (2012-2016) 15

Figure Sales Market Share of Fidaxomicin by Countries (2012-2016) 15

Figure Sales Market Share of Fidaxomicin by Countries in 2015 16

Table Europe Fidaxomicin Revenue (M USD) by Countries (2012-2016) 16

Table Europe Fidaxomicin Revenue Share by Countries (2012-2016) 17

Figure Revenue Market Share of Fidaxomicin by Countries (2012-2016) 17

Table Europe Fidaxomicin Sales (K Tablets) by Application (2012-2016) 17

Table Europe Fidaxomicin Sales Share by Application (2012-2016) 18

Figure Sales Market Share of Fidaxomicin by Application (2012-2016) 18

Figure Sales Market Share of Fidaxomicin by Application in 2015 19

Figure Germany Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 20

Figure Germany Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 21

Figure Germany Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 21

Table Germany Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 22

Table Germany Fidaxomicin Market Share by Manufacturers (2015 and 2016) 22

Table Germany Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 22

Table Germany Fidaxomicin Market Share by Applications (2015 and 2016) 23

Figure UK Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 24

Figure UK Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 25

Figure UK Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 26

Table UK Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 26

Table UK Fidaxomicin Market Share by Manufacturers (2015 and 2016) 26

Table UK Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 27

Table UK Fidaxomicin Market Share by Applications (2015 and 2016) 27

Figure France Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 28

Figure France Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 29

Figure France Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 29

Table France Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 30

Table France Fidaxomicin Market Share by Manufacturers (2015 and 2016) 30

Table France Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 30

Table France Fidaxomicin Market Share by Applications (2015 and 2016) 30

Figure Russia Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 32

Figure Russia Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 33

Figure Russia Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 33

Table Russia Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 34

Table Russia Fidaxomicin Market Share by Manufacturers (2015 and 2016) 34

Table Russia Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 34

Table Russia Fidaxomicin Market Share by Applications (2015 and 2016) 34

Figure Benelux Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 36

Figure Benelux Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 37

Figure Benelux Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 37

Table Benelux Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 38

Table Benelux Fidaxomicin Market Share by Manufacturers (2015 and 2016) 38

Table Benelux Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 38

Table Benelux Fidaxomicin Market Share by Applications (2015 and 2016) 38

Figure Italy Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 40

Figure Italy Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 41

Figure Italy Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 41

Table Italy Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 42

Table Italy Fidaxomicin Market Share by Manufacturers (2015 and 2016) 42

Table Italy Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 42

Table Italy Fidaxomicin Market Share by Applications (2015 and 2016) 42

Figure Spain Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 44

Figure Spain Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 45

Figure Spain Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 45

Table Spain Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 46

Table Spain Fidaxomicin Market Share by Manufacturers (2015 and 2016) 46

Table Spain Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 46

Table Spain Fidaxomicin Market Share by Applications (2015 and 2016) 46

Table Astellas Basic Information List 48

Figure Picture of Fidaxomicin 49

Table Astellas Fidaxomicin Product Information 49

Table Astellas Fidaxomicin Sales, Revenue, Price and Gross Margin 2015-2016 50

Table Key Raw Materials of Fidaxomicin 51

Table Suppliers of Raw Materials 52

Figure Manufacturing Cost Structure of Fidaxomicin 54

Figure Manufacturing Process Analysis of Fidaxomicin 55

Figure Fidaxomicin Industrial Chain Analysis 57

Table Major Buyers of Fidaxomicin 58

Figure Marketing Channel for Fidaxomicin 59

Table Distributors/Traders List 67

Figure Germany Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 69

Figure Germany Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 70

Figure UK Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 70

Figure UK Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 71

Figure France Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 71

Figure France Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 72

Figure Russia Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 73

Figure Russia Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 73

Figure Benelux Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 74

Figure Benelux Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 74

Figure Italy Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 75

Figure Italy Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 76

Figure Spain Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 76

Figure Spain Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 77

Table Europe Fidaxomicin Sales (K Tablets) Forecast by Application (2016-2021) 77

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370